1. CDC. Interim clinical considerations for use of JYNNEOS and ACAM2000 vaccines during the 2022 U.S. monkeypox outbreak. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. Updated October 19, 2022. https://www.cdc.gov/poxvirus/monkeypox/clinicians/vaccines/vaccine-considerations.html
2. Food and Drug Administration. JYNNEOS [package insert, revised June 2021]. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2021. https://www.fda.gov/media/131078/download
3. Food and Drug Administration. Emergency use authorization for the emergency use of JYNNEOS. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2022. https://www.fda.gov/media/160774/download
4. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).;Shimabukuro;Vaccine,2015
5. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel.;Halsell;JAMA,2003